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Summary. Deletions are the most common  molecular  
defect in steroid sulfatase (STS) deficiency. We describe 
the application of multiplex D N A  amplification, by poly- 
merase  chain reaction, for deletion screening in patients 
with STS deficiency (STS-PCR).  Genomic  D N A  from 38 
unrelated patients was amplified using two sets of prim- 
ers, corresponding to the 5' and the 3' ends of the STS 
gene. The analysis of the amplified products  was always 
consistent with the results obtained by Southern analy- 
sis. This method represents a sensitive fast non-radioac- 
tive test for detecting STS gene deletions. 
Introduction 
X-linked ichthyosis (XLI)  as a result of steroid sulfatase 
(STS) deficiency is one of the most  common X-linked 
disorders (see Shapiro 1989 for review). We have re- 
cently demonstra ted ,  in a multicenter study, that 48 out 
of 57 unrelated patients with STS deficiency (84%) dis- 
play an entire gene deletion (Ballabio et al. 1989a). 
Simultaneous amplification by polymerase  chain re- 
action (PCR) of widely separated sequences (multiplex 
D N A  amplification) is a fast non-radioactive method for 
scanning for deletions at a particular locus. We have pre- 
viously shown the feasibility of this technique for deletion 
screening at the Duchenne muscular dystrophy (DMD)  
locus (Chamberlain  et al. 1988). Here  we describe the 
application of this method for deletion screening in STS 
deficiency. 
Materials and methods 
Patients' DNA was obtained from blood or fibroblasts and ana- 
lyzed using the standard Southern blotting procedure. A full 
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length STS cDNA probe, 7A5B, obtained from the screening of a 
placental cDNA library using a previously isolated STS cDNA 
clone (Ballabio et al. 1987), was used in the Southern analysis. 
The STS gene is composed of 10 exons that span a region of 
about 140 kb (Yen et al. 1989). Two sets of olinucleotide primers 
have been designed using sequence information obtained from 
previously isolated cDNA and genomic clones from the STS gene 
(Ballabio et al. 1987; Yen et al. 1989). The sequence of these prim- 
ers and the size of the amplified regions are listed in Table 1. They 
amplify two regions, one located approximately 900bp upstream 
from the initiation site of the STS gene (set 1), and the other con- 
taining the termination site in exon 10 (set 2). The primer se- 
quences are sufficiently divergent from the corresponding Y-chro- 
mosome STS pseudogene regions to prevent spurious amplifica- 
tion of Y-specific sequences. A further set, corresponding to a 
547 bp exon-containing region of the dystrophin gene (primer set E 
in Chamberlain et al. 1988), was used as an internal control for the 
reactions. 
DNA amplification was performed essentially as previously 
described (Chamberlain et al. 1988). Primers were annealed at 
60°C for 30 s; 2 min extension times at 72°C were used. Thirty cy- 
cles of amplification were performed using the buffer described by 
Saiki et al. (1988). 
Results 
Figure 1A shows the results obtained by hybridization of 
probe  7A5B with E c o R I  restricted D N A  from 11 pa- 
tients with STS deficiency and one male control. Both X 
and Y specific bands were detected in the control lane 
(lane 12), corresponding to the STS gene and pseudo- 
gene, respectively. X-specific bands were not detected in 
lanes 1, 4, 5, 7, 8, 9 and 10, indicating an entire STS gene 
deletion (the remaining bands correspond to the STS Y 
pseudogene).  In lane 2, a partial deletion was observed,  
as previously repor ted (case AB,  Ballabio et al. 1989a). 
A normal  pat tern was detected in lanes 3, 6 and 11. 
Figure 1B shows the STS amplification reaction pro- 
ducts (STS-PCR) obtained with the D N A  from the same 
patients as in Fig. 1A, and in the same order.  Each sam- 
ple displayed the presence of the D M D  band (band a) 
demonstrat ing that the D N A  was suitable for amplifica- 
tion. Amplification of the STS gene was entirely consis- 
tent with the Southern analysis shown in Fig. 1A. The 
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Table 1. STS-PCR oligonucleotide primers 
Primer set Sequence 
1) 5'STS gene F-5'GGCCTAGAAGAAGGTTGAAGGTCCC 
R-5'AAGAGGTI'GGATGAGATGGGCATAC 





tion in 32 cases, a partial deletion in one case, and a nor- 
mal amplification pattern in 5 cases (data not shown). 
Fig. 1. A Southern analysis of EcoRI digested DNA samples from 
11 patients with STS deficiency (lanes 1-11) and one male control 
(lane 12) using the STS full length cDNA clone 7A5B. B Multiplex 
DNA amplification of the STS gene (STS-PCR) in 11 patients with 
STS deficiency (lanes 1-11, loaded in the same order as in A) and 
one male control (lane 12). Band a corresponds to an exon of the 
DMD gene and was used as an internal control for the amplifica- 
tion. Bands b and c correspond to the 3' and the 5' ends of the STS 
gene, respectively. M W  X DNA digested with HaeIII 
patients'  D N A  in lanes 1, 4, 5, 7, 8, 9 and 10 was unable 
to amplify either band b or c. D N A  in lane 2, from the 
patient with a deletion involving only the 3' end of the 
gene, showed the absence of band b and the presence of 
band c (lane 2). D N A  in lanes 3, 6, 11 and 12 showed a 
normal amplification pattern. A total of 38 Italian pa- 
tients with STS deficiency have been analyzed by STS- 
PCR and the results in each case are consistent with the 
Southern analysis, demonstrating an entire gene dele- 
Discuss ion  
The application of DNA amplification to the molecular 
analysis of genetic disorders is becoming increasingly 
common (Erlich 1989). Multiplex DNA amplification is 
a facile rapid non-radioactive method for deletion screen- 
ing at a particular locus, requiring less than 500 ng DNA 
and allowing direct visualization on ethidium bromide 
stained gels of amplified products from the locus of in- 
terest. This technique is particularly useful for those dis- 
eases in which deletions are present in a large percentage 
of patients and in which molecular analysis by conven- 
tional Southern blotting would require hybridization 
with several probes. STS deficiency is a Mendelian disor- 
der with an extremely high frequency of deletions (84%) 
(Ballabio et al. 1989a). This makes it an ideal system for 
the use of a multiplex DNA amplification screening test. 
We have designed two sets of primers amplifying re- 
gions at the 5' and the 3' ends of the STS gene. Although 
these primers would not recognize internal deletions, we 
were able to detect a deletion in 100% (33 cases) of the 
patients previously found to have deletions by conven- 
tional Southern analysis. Entire gene deletion is by far 
the most common observation in patients with STS defi- 
ciency, only one patient with an internal gene deletion 
being described (Yen et al. 1987). Therefore,  our meth- 
od represents a reliable screening test for STS gene dele- 
tions. 
We have recently demonstrated that deletions of the 
STS gene may involve adjacent loci, sometimes causing 
contiguous gene syndromes (Ballabio et al. 1989b). Se- 
quence analysis of these adjacent loci could enable ex- 
pansion of the STS multiplex reaction to screen for con- 
tiguous gene syndromes. Such a reaction would provide 
a rapid method for the detection and partially characteri- 
zation of deletions leading to contiguous gene syndromes 
throughout the Xp22.3 region. Multiplex PCR requires 
less than 5 h for complete analysis, and is therefore ide- 
ally suited for routine screening of patient DNA for de- 
letions leading to genetic disease. Furthermore,  the use 
of fluorescently labeled PCR primers enables almost 
fully automatic analysis of patient DNA with the con- 
secutive use of an automatic thermocycler and a DNA 
sequencing apparatus (J. S. Chamberlain and C.T.  Cas- 
key unpublished observations). Multiplex amplification 
reactions could also be used to characterize rapidly so- 
matic cell hybrids or to screen yeast artificial chromo- 
some  ( Y A C )  l ib rar ies  for  the  iden t i f i ca t ion  of  c lones  
con ta in ing  la rge  reg ions  o f  D N A  f lanking  a pa r t i cu l a r  
locus.  Such r eac t ions  shou ld  t h e r e f o r e  p r o v e  useful  b o t h  
for  rou t ine  d i sease  screening  and  for  gene  m a p p i n g  and  
c loning  e x p e r i m e n t s  r e l a t ed  to the  h u m a n  g e n o m e  p ro -  
jec t .  
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Note added in proof. Since this paper was submitted, the PCR 
primers described here have been successfully used for the isola- 
tion of five yeast artificial chromosome (YAC) clones spanning the 
entire STS gene and flanking loci. 
